Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pros-Simón, Ana
15  Ergebnisse:
Personensuche X
?
1

Aortic Vasculitis in Patient With Systemic Lupus Erythemato..:

Pérez Ruiz, José ; Salman-Monte, Tarek Carlos ; Pros-Simón, Ana..
Reumatología Clínica (English Edition).  12 (2016)  3 - p. 169-172 , 2016
Link: https://doi.org/10.1016/..
 
?
2

Tenosynovial giant cell tumor mimicking an ankle monoarthri..:

Vílchez-Oya, Francisco ; Pros Simón, Ana
Vílchez-Oya F, Pros A. Tenosynovial giant cell tumor mimicking an ankle monoarthritis. Eur J Rheumatol. 2020 Apr 28; 7(4):203–4. DOI:10.5152/eurjrheum.2020.19197.  ,
Link: http://hdl.handle.net/10..
 
?
3

Prevalence and risk factors of left ventricular diastolic d..:

Morales Murillo, R ; Belarte Tornero, L ; Pros Simon, A...
European Heart Journal.  44 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
4

Serum Advanced Glycation End Products and Their Soluble Rec..:

Carrión-Barberà, Irene ; Triginer, Laura ; Tío, Laura...
Biomedicines.  12 (2024)  3 - p. 610 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Role of Advanced Glycation End Products as New Biomarkers i..:

Carrión-Barberà, Irene ; Triginer, Laura ; Tío, Laura...
International Journal of Molecular Sciences.  25 (2024)  5 - p. 3022 , 2024
Link: https://doi.org/10.3390/..
 
?
6

Left ventricular dysfunction and arrhythmias in asymptomati..:

López Núñez, Lilian ; Carrión-Barberà, Irene ; Molina, Luis...
Medicina Clínica (English Edition).  160 (2023)  10 - p. 434-442 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Le tocilizumab peut induire une hypogammaglobulinémie secon..:

Vílchez-Oya, Francisco ; Pros, Ana ; Carrión-Barberà, Irene...
Revue du Rhumatisme.  88 (2021)  2 - p. 152-155 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Tocilizumab may induce secondary hypogammaglobulinaemia. A ..:

Vílchez-Oya, Francisco ; Pros, Ana ; Carrión-Barberà, Irene...
Joint Bone Spine.  87 (2020)  5 - p. 503-505 , 2020
Link: https://doi.org/10.1016/..
 
?
9

The use of tocilizumab in the treatment of refractory eosin..:

Vílchez-Oya, Francisco ; Sánchez-Schmidt, Julia María ; Agustí, Anna.
Clinical Rheumatology.  39 (2020)  5 - p. 1693-1698 , 2020
Link: https://doi.org/10.1007/..
 
?
10

MYC activation impairs cell-intrinsic IFNγ signaling and co..:

Alburquerque-Bejar, Juan J. ; Navajas-Chocarro, Pablo ; Saigi, Maria...
Cell Reports Medicine.  4 (2023)  4 - p. 101006 , 2023
Link: https://doi.org/10.1016/..
 
?
11

SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and K..:

Romero, Octavio A. ; Vilarrubi, Andrea ; Alburquerque-Bejar, Juan J....
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
12

Deep analysis of acquired resistance to FGFR1 inhibitor ide..:

Gimenez-Xavier, Pol ; Pros, Eva ; Aza, Ana...
Oncotarget.  9 (2018)  59 - p. 31549-31558 , 2018
Link: https://doi.org/10.18632..
 
?
13

Determining the profiles and parameters for gene amplificat..:

Pros, Eva ; Lantuejoul, Sylvie ; Sanchez‐Verde, Lydia...
International Journal of Cancer.  133 (2013)  4 - p. 898-907 , 2013
Link: https://doi.org/10.1002/..
 
?
14

Assessing the RNA effect of 26 DNA variants in the BRCA1 an..:

Menéndez, Mireia ; Castellsagué, Joan ; Mirete, Marc...
Breast Cancer Research and Treatment.  132 (2011)  3 - p. 979-992 , 2011
Link: https://doi.org/10.1007/..
 
?
15

Patient-reported outcome measures in severe asthma: an expe..:

Martínez-Moragón, Eva ; Antepara Ercoreca, Ignacio ; Muñoz García, María...
Journal of Asthma.  61 (2023)  6 - p. 619-631 , 2023
Link: https://doi.org/10.1080/..
 
1-15